SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?


To: sim1 who wrote (398)9/16/1999 12:52:00 AM
From: RWReeves  Respond to of 555
 
Thanks Stuart,

I remember some of this primer from my mis-spent schooling, when the discussion was still largely theoretical.

<Future acquisition or reabsorption into the parent company is usually the sole anticipation of reward for tracking stocks.>

Pretty much says it all. If they don't want to buy it back, they won't. So no competitive bidding that makes our "efficient" market. Hence a stunted upside.

As you point out there is also technically a free "no bankruptcy" put included, although I suppose that only means it can't go much below cash value per share.

GZMO doesn't always seem to act like it had a floating call and built-in toxic, but I think that's the "synthetic" for the tracking stock. My guess is that it lends itself to shorting since there isn't much chance of a sudden tender offer, and the upward bounce on news usually has a looooong time to translate into real earnings and hence value to the parent. GZMO does drop pretty fast from the heights, don't it?

Appreciate the discussion. Hope it's been of help to others but don't mean to monopolize the thread.

RWR